Lappe Mark

CIK 00013660744 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001366074

Recent Transactions

48 trades

Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$112.28/sh+9,681→ 730,548 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$100.64/sh+6,605→ 718,048 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$99.29/sh+5,895→ 711,443 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$107.12/sh+1,100→ 719,148 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$108.23/sh+500→ 719,648 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2026-09-08$111.88/sh+1,219→ 720,867 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-16$17.13/sh+13,037→ 705,548 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-12$15.05/sh+26,963→ 692,511 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-10$15.19/sh+8,500→ 665,548 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-09$15.21/sh+9,500→ 657,048 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-06$15.29/sh+26,000→ 647,548 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-03$15.66/sh+15,288→ 160,288 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-09-03$16.31/sh+4,712→ 165,000 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-30$14.02/sh+10,000→ 145,000 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-29$14.03/sh+10,000→ 135,000 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-21$12.93/sh+12,945→ 54,865 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-20$12.97/sh+27,055→ 41,920 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−59,462→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−145,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−2,486,192→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Common Stock
2024-05-30$30.00/sh−500,000→ 0 total
Disposition to Issuer
Inhibrx, Inc.
Stock Option (right to buy)
2024-05-30−100,000→ 0 total
Award
Inhibrx Biosciences, Inc.$INBX
Stock Option (right to buy)
2024-05-30+300,000→ 300,000 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+621,548→ 621,548 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+125,000→ 125,000 total
Award
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-05-29+14,865→ 14,865 total
Sale
Inhibrx, Inc.
Common Stock
2023-02-28$25.02/sh−60→ 2,486,192 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Sale
Inhibrx, Inc.
Common Stock
2022-12-19$26.29/sh−754→ 2,512,252 total
Sale
Inhibrx, Inc.
Common Stock
2022-12-19$25.53/sh−25,246→ 2,513,006 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$28.86/sh−1,767→ 2,547,087 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$30.15/sh−6,773→ 2,540,314 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$30.67/sh−912→ 2,539,402 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$32.38/sh−1,150→ 2,538,252 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$25.36/sh−6,959→ 2,557,293 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$26.57/sh−4,106→ 2,553,187 total
Sale
Inhibrx, Inc.
Common Stock
2022-11-17$27.45/sh−4,333→ 2,548,854 total
Sale
Inhibrx, Inc.
Common Stock
2022-10-17$31.51/sh−121→ 2,564,252 total
Sale
Inhibrx, Inc.
Common Stock
2022-10-17$30.81/sh−2,892→ 2,564,373 total
Sale
Inhibrx, Inc.
Common Stock
2022-10-17$29.92/sh−14,006→ 2,567,265 total
Sale
Inhibrx, Inc.
Common Stock
2022-10-17$28.66/sh−8,981→ 2,581,271 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2021-01-15+145,000→ 145,000 total
Gift
Inhibrx, Inc.
Common Stock
2020-12-28+500,000→ 500,000 total
Gift
Inhibrx, Inc.
Common Stock
2020-12-28−500,000→ 2,590,252 total
Award
REPROS THERAPEUTICS INC.
Stock Option (Right to Buy)
2009-05-20+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O INHIBRX BIOSCIENCES, INC. 11025 NORTH TORREY PINES ROAD, SUITE 140

LA JOLLA, CA, 92037

View on SEC.gov